Ventolin

Showing 2 posts of 2 posts found.

GSK’s low carbon inhaler, Ventolin, progresses to phase 3 trials 

November 21, 2023
Medical Communications Asthma & COPD, GSK, Ventolin, asthma, carbon-neutral

GSK has announced that in 2024 it intends to start phase 3 trials of a low carbon version of its …

gsk_wall

GSK hit by recall of 600,000 inhalers

April 5, 2017
Manufacturing and Production, Research and Development FDA, GSK, Ventolin

The FDA has released that GSK would be voluntarily recalling close to 600,000 of its Ventolin asthma inhalers across the …

The Gateway to Local Adoption Series

Latest content